TEVA PHARMACEUTICAL INDUSTRIES LTD 6-K

FORM 6-K

THIRD SUPPLEMENTAL SENIOR INDENTURE, DATED AS OF MARCH 16, 2010

XBRL INSTANCE DOCUMENT

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: Contingencies:

IDEA: Earnings per share:

IDEA: Convertible senior debentures:

IDEA: Certain transactions:

IDEA: Legal settlements, acquisition and restructuring expenses and impairment:

IDEA: Revenue recognition:

IDEA: CONSOLIDATED BALANCE SHEETS

IDEA: Entity-wide disclosures:

IDEA: Fair value measurement:

IDEA: XBRL DOCUMENT

IDEA: CONSOLIDATED BALANCE SHEETS (Parenthetical)

IDEA: Derivative instruments and hedging activities:

IDEA: Inventories:

IDEA: Supplemental disclosure of non-cash financing activities:

IDEA: CONSOLIDATED STATEMENTS OF CASH FLOW

IDEA: XBRL DOCUMENT

IDEA: Comprehensive income (loss):

IDEA: Document and Entity Information

IDEA: CONSOLIDATED STATEMENTS OF INCOME

IDEA: XBRL DOCUMENT

IDEA: XBRL DOCUMENT

IDEA: Basis of presentation:

IDEA: Recently adopted accounting pronouncements: